North America
& Hawaii
& Hawaii
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. The statements made within this website have not been evaluated by the US Food and Drug Administration.
$208.00
7 in stock
90 capsules, 6mg each.
Orforglipron – Oral GLP-1 Research Analog
Orforglipron is a next-generation small-molecule GLP-1 receptor agonist designed for advanced studies in appetite regulation, glucose homeostasis, and body weight modulation. Its oral activity makes it an attractive candidate for exploring mechanisms that differ from traditional injectable peptide-based GLP-1 analogs.
• High-purity research-grade compound
• Suitable for metabolic and obesity pathway investigations
Key Research Highlights
• Mechanism of interest: Selective agonism of the GLP-1 receptor, supporting research into satiety signaling, insulin secretion, and glycemic control.
• Application focus: Obesity, type 2 diabetes, and cardiometabolic risk-factor modeling in non-clinical settings.
• Form factor: Oral small molecule, enabling differentiated study designs versus injectable peptide comparators.
• Amino sequence: Not applicable (non-peptide small molecule).
• Molecular weight: Approximately 882.9–883.0 g/mol.
• CAS Number: 2212020-52-3
Orders Over $250
100% Secure Payment
Ready to Help
& Hawaii Shipping
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent for research purposes only. Research supplies (e.g., syringes, bacteriostatic water) are not included. No dosing instructions are provided. We adhere to all local and state laws around Research Only Chemical sales. We are not a pharmacy, nor do we promote or provide any advice for human or animal consumption.
Please review our terms and conditions carefully before making a purchase on our website. You must be 21+ and a licensed research professional By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated here.
